http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106588913-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-444 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106588913-B |
| titleOfInvention | With Imidazopyridine-derivatives, preparation and its application in medicine |
| abstract | The invention discloses with Imidazopyridine-derivatives, preparation and its application in medicine.Specifically, the present invention relates to new derivative and its pharmaceutical salt shown in a kind of logical formula (I) or containing its pharmaceutical composition, and preparation method thereof.The invention also discloses the derivative and its pharmaceutical salt or containing its pharmaceutical composition in Bruton tyrosine kinase inhibitors, and the application in preparing the drug for the treatment of and/or the diseases such as pre- preventing tumor and inflammation.Each substituent group of its formula of (I) is identical with the definition in specification. |
| priorityDate | 2015-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 162.